
    
      This feasibility study is a prospective, multi-center, single-arm study of the CATERPILLAR™
      Arterial Embolization Device. Up to twenty (20) subjects will be treated with the
      CATERPILLAR™ Arterial Embolization Device at up to 5 investigational sites in New Zealand and
      Australia.
    
  